Biotech Valuation Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation

CRSP 56.38

-0.5%

3:40 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: scaram(o)uche who wrote (9413)	11/5/2003 12:18:49 PM
From: Ian@SI	Read Replies (2) of 52153

If anyone really wants to try to convince JAMA to change their policy, the following link might be of value... sec.gov Personally, I believe that ESPR is in violation of Reg FD. They fully understood that material insider information given to JAMA would be selectively disclosed; and that this would significantly disadvantage any non subscriber to JAMA. I believe this selective disclosure violates both the spirit and the letter of Reg FD. FWIW, Ian

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next